A randomized Phase 2a study to assess pharmacodynamics, antitumor activity and safety of intravenous BAL101553, a novel microtubule inhibitor, at two dose levels in adult patients with selected advanced solid tumors.

作者:Kristeleit Rebecca Sophie; Smith Alan D; Haris Noor R Md; Zubairi Ishtiaq Husain; King Judy W; Luken Maria Jose de Miguel; D'Arcangelo Manolo; MacDonald Julie; Brown Nicholas F; Calvert Alan Hilary; Hannah Alison L; Anderson Stephanie; Bachmann Felix; Maurer Martina; Schmitt Hoffmann Anne; Lane Heidi A; Engelhardt Marc Frederick; Evans T R Jeffry; Plummer Ruth; Molife L Rhoda
来源:Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 2015-05-29 to 2015-06-02.
  • 出版日期2015-5-20